VANGL1 and central nervous system cancer: Immunohistochemical assessments of KITENIN expression in glioma tissue samples from 86 patients showed that this protein was highly expressed in seven of 33 low-grade gliomas (21.2%) and in 28 of 53 high-grade tumors (52.8%) (Fig. 1D).